Arteris (NASDAQ:AIP) Price Target Raised to $38.00

Arteris (NASDAQ:AIP) had its price target boosted by equities research analysts at Rosenblatt Securities from $20.00 to $38.00 in a report released on Wednesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Rosenblatt Securities’ price target would indicate a potential upside of 17.18% from the company’s current price.

Other equities research analysts have also recently issued reports about the stock. Wall Street Zen cut shares of Arteris from a “buy” rating to a “hold” rating in a report on Saturday, May 2nd. Northland Securities set a $24.00 price target on Arteris in a research report on Friday, February 13th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Arteris in a research note on Monday, April 20th. Finally, Jefferies Financial Group reaffirmed a “hold” rating and set a $35.00 price objective on shares of Arteris in a research report on Wednesday. Two equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $28.38.

Arteris Stock Performance

AIP opened at $32.43 on Wednesday. Arteris has a one year low of $6.88 and a one year high of $33.46. The stock has a market capitalization of $1.49 billion, a P/E ratio of -39.55 and a beta of 1.93. The business’s 50-day simple moving average is $20.37 and its 200-day simple moving average is $17.15.

Arteris (NASDAQ:AIP) last released its quarterly earnings results on Thursday, February 12th. The company reported ($0.05) EPS for the quarter, beating the consensus estimate of ($0.08) by $0.03. The business had revenue of $20.14 million during the quarter, compared to analysts’ expectations of $18.55 million. On average, equities research analysts forecast that Arteris will post -0.68 EPS for the current fiscal year.

Insider Transactions at Arteris

In related news, major shareholder Bayview Legacy, Llc sold 70,000 shares of the business’s stock in a transaction dated Friday, May 8th. The shares were sold at an average price of $31.20, for a total transaction of $2,184,000.00. Following the sale, the insider owned 9,049,071 shares of the company’s stock, valued at approximately $282,331,015.20. The trade was a 0.77% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO K Charles Janac sold 70,000 shares of the company’s stock in a transaction dated Friday, May 8th. The stock was sold at an average price of $31.20, for a total transaction of $2,184,000.00. Following the transaction, the chief executive officer owned 9,049,071 shares in the company, valued at $282,331,015.20. The trade was a 0.77% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 866,923 shares of company stock valued at $18,543,293. 33.70% of the stock is owned by company insiders.

Hedge Funds Weigh In On Arteris

Several hedge funds have recently bought and sold shares of AIP. Raymond James Financial Inc. purchased a new position in shares of Arteris in the second quarter valued at $32,000. BNP Paribas Financial Markets grew its stake in Arteris by 75.0% in the 3rd quarter. BNP Paribas Financial Markets now owns 6,053 shares of the company’s stock valued at $61,000 after acquiring an additional 2,595 shares during the last quarter. Strs Ohio acquired a new stake in Arteris in the 1st quarter valued at about $104,000. Penn Capital Management Company LLC purchased a new position in Arteris during the 3rd quarter valued at about $109,000. Finally, Susquehanna Fundamental Investments LLC acquired a new position in Arteris during the third quarter worth about $113,000. 64.36% of the stock is owned by hedge funds and other institutional investors.

More Arteris News

Here are the key news stories impacting Arteris this week:

• Positive Sentiment: Arteris beat Q1 expectations, reporting a loss of $0.03 per share versus the expected $0.08 loss, while revenue of $22.94 million also came in above estimates. Article Title
• Positive Sentiment: Management raised revenue guidance for Q2 2026 to $23.0 million-$24.0 million and FY2026 to $91.0 million-$95.0 million, signaling confidence in continued growth. Article Title
• Neutral Sentiment: The earnings call transcript and related materials may offer more detail on customer wins, margin trends, and the outlook for AI-related semiconductor demand. Article Title
• Negative Sentiment: Major shareholder Bayview Legacy, LLC sold 70,000 shares at $31.20, and CEO K. Charles Janac also sold 70,000 shares, which can weigh on sentiment even though the sales were relatively small versus their remaining holdings. Article Title

About Arteris

Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.

Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.